News Article | May 17, 2017
CLEVELAND - Results from the DAWN stroke trial presented at the European Stroke Organization Conference (ESOC) provide compelling evidence that selected patients suffering a major ischemic stroke recovered significantly better with mechanical retrieval of the blood clot with medical therapy compared with medical therapy alone when initiated past the current guidelines of within 6 hours and up to 24 hours of the stroke. University Hospitals Cleveland Medical Center was one of the top seven recruiting sites in the multi-site study that enrolled a total of 206 patients in the nation. The results showed that patients treated with the retrieval system, known as mechanical thrombectomy, had significantly decreased post-stroke disability and improved functional independence at 90 days compared to medical management alone. "This is incredible," said Cathy Sila, MD, Director of UH's Comprehensive Stroke Center, and principal investigator of the study at the UH site. "Almost half of the patients (48.6 percent) receiving the thrombectomy therapy had a good outcome at 90 days after treatment--defined as the patients being independent in activities of daily living--as opposed to only 13.1 percent of the patients treated medically or with clot-busting drugs alone. This 35 percent difference may be higher than any level of benefit from any stroke trial." "Not only did the patients treated with mechanical thrombectomy dramatically improve during hospitalization, sometimes being able to walk and be discharged to home, but there was also a much lower risk of subsequent neurological worsening because of the poor blood flow to the brain," said Dr. Sila. "The number of patients needed to treat to achieve a good outcome was 2.8. This is a much greater chance of response than what was seen in trials that did not routinely use advanced brain imaging to guide treatment," she said. "We have long believed in the usefulness of MRI scans to define appropriateness of treatment. UH had been using a similar MRI protocol since 2010, five years before the DAWN trial began in 2015." Anthony Furlan, MD, Chairman of the Department of Neurology at UH and Case Western Reserve University School of Medicine, was on the DAWN study's steering committee and helped write the study protocol. "These results provide physicians who treat stroke with evidence of the benefits of thrombectomy even when administered out as far as 24 hours, and should help to make decisions clearer as to which patients to treat," said Dr. Furlan. "These positive outcomes of the DAWN trial represent a major change in patient selection for endovascular therapy for stroke," he said. In the study, researchers used neuroimaging to determine which patients would likely benefit from the procedure. According to Dr. Sila, they would examine how much brain tissue had suffered irreversible damage and how much might be able to be saved. If the amount of damaged tissue were no bigger than the size of a small apricot, researchers believed the patient could benefit from the therapy. Neuro-interventionists would then use a mechanical stent retriever called the Trevo Retriever to remove the blood clot, followed by treatment with the clot-busting medication. The study had been stopped earlier this year after an FDA-approved planned interim review by the independent Data Safety Monitoring Board (DSMB) of data from the first 200 patients enrolled nationally because there was such a dramatic difference between the two arms of the study. The study had been designed to enroll up to a maximum of 500 patients. Dr. Sila said that in Northeast Ohio, we have about 18,000 strokes per year. Stroke survivors commonly experience devastating disabilities and loss of independence due to impaired movement, paralysis, loss of speech and memory. Randomized clinical data has proven the benefit of mechanical thrombectomy with stent retrievers in helping patients with large vessel occlusion strokes, but these devices have only been indicated to reduce disability if used within six hours of stroke onset. "For patients presenting with stroke symptoms beyond six hours, the benefit of clot retrieval using a stent retriever was unknown," said Dr. Furlan. "Now we have evidence that for patients who present to the hospital outside of the six hour time window could have a better chance for an independent life with improved clinical outcomes. Although this is great news, earlier treatment is always better because with stroke 'time is brain.'" The study was supported by Stryker, which produces the Trevo Retriever, a tiny stent-shaped medical device that is attached to a thin wire. The retriever is designed to ensnare the blood clot to remove it from a blood vessel. UH is working with Case Western Reserve University to develop the Cleveland Brain Health Initiative, linking this kind of leading edge neuroscience work from CWRU, UH, Cleveland Clinic, MetroHealth Medical Center and the Louis Stokes Cleveland VA Medical Center to advance progress therapy and treatment of devastating neurological diseases. A video of a UH patient who was in the DAWN trial at: http://www. The DAWN trial is an international, multi-center, blinded endpoint assessment, randomized study. The purpose of the study is to demonstrate superior clinical outcomes at 90 days with Stryker's Trevo Retriever plus medical management compared to medical management alone in appropriately selected patients treated six to 24 hours after last seen well. The Trevo Retriever indication within the DAWN Trial is currently approved for investigational use only by the U.S. Food and Drug Administration in the United States under an Investigational Device Exemption (IDE) study approval. Founded in 1866, University Hospitals serves the needs of patients through an integrated network of 18 hospitals, more than 40 outpatient health centers and 200 physician offices in 15 counties throughout northern Ohio. The system's flagship academic medical center, University Hospitals Cleveland Medical Center, located on a 35-acre campus in Cleveland's University Circle, is affiliated with Case Western Reserve University School of Medicine. The main campus also includes University Hospitals Rainbow Babies & Children's Hospital, ranked among the top children's hospitals in the nation; University Hospitals MacDonald Women's Hospital, Ohio's only hospital for women; and University Hospitals Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women's health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and urology. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including "America's Best Hospitals" from U.S. News & World Report. UH is also home to Harrington Discovery Institute at University Hospitals - part of The Harrington Project for Discovery & Development. UH is the second largest employer in northern Ohio with 26,000 employees. For more information, go to UHhospitals.org. The Trevo Retriever is a tiny stent-shaped medical device that is attached to a thin wire. In a minimally invasive procedure that utilizes X-ray, the physician navigates the retriever from the femoral artery (located in the upper leg) to the blocked blood artery in the brain. The retriever is designed to ensnare the blood clot and remove it from the body. Originally cleared by the FDA in 2012 for the revascularization of patients experiencing ischemic stroke, the Trevo Retriever has been used in thousands of patients worldwide. Stryker's Trevo Retriever was the only mechanical thrombectomy device used in this trial. An animation of Stryker's Trevo Retriever is available here: https:/ An ischemic stroke occurs when an artery in the brain becomes blocked by a blood clot or other substance such as plaque, a fatty material. Blood vessels carry blood, oxygen and nutrients throughout the body and to the brain. When the brain is deprived of blood and oxygen, it fails to work properly. Depending on the severity of the stroke and the area of the brain affected, loss of brain function or death may occur. According to the World Heart Federation, ischemic stroke contributes to nearly six million deaths around the globe. Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world. Please contact us for more information at http://www.
News Article | May 24, 2017
Letters of Intent are being accepted through July 19, 2017. All applications must be submitted online at HarringtonDiscovery.SmartSimple.com. Harrington Discovery Institute will select up to 10 researchers to receive the Harrington Rare Disease Scholar Award. Scholars will work closely with drug development experts from its Innovation Support Center, which provides hands-on industry guidance not found in traditional academic research settings. Harrington Rare Disease Scholars and their institutions retain the intellectual property rights to their work. The award is open to MD PhD researchers at accredited academic medical centers, research institutions, and universities in the United States. Selection criteria include innovation, creativity and potential for impact on human health. Award recipients will be selected by Harrington Discovery Institute's Scientific Advisory Board for Rare Diseases and announced in early 2018. Harrington Discovery Institute The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio – part of The Harrington Project for Discovery & Development – aims to advance medicine and society by enabling our nation's most inventive physician-scientists to turn their discoveries into medicines that improve human health. The institute was created in 2012 with a $50 million founding gift from the Harrington family and instantiates the commitment they share with University Hospitals to a Vision for a 'Better World'. The Harrington Project for Discovery & Development The Harrington Project for Discovery & Development (The Harrington Project), founded in late February 2012 by the Harrington Family and University Hospitals of Cleveland, is a $300 million national initiative built to bridge the translational valley of death. It includes the Harrington Discovery Institute and BioMotiv, a for-profit, mission-aligned drug development company that accelerates early discoveries into medicines for benefit of society. For more information about The Harrington Project and Harrington Discovery Institute, visit: HarringtonDiscovery.org. About University Hospitals Founded in 1866, University Hospitals serves the needs of over 1 million patients per year through an integrated network of 18 hospitals, more than 40 outpatient health centers and 200 physician offices in 15 counties throughout northern Ohio. The system's flagship academic medical center, University Hospitals Cleveland Medical Center, located on a 35-acre campus in Cleveland's University Circle, is affiliated with Case Western Reserve University School of Medicine. The main campus also includes University Hospitals Rainbow Babies & Children's Hospital, ranked among the top children's hospitals in the nation; University Hospitals MacDonald Women's Hospital, Ohio's only hospital for women; and University Hospitals Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women's health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, dermatology, transplantation and urology. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including "America's Best Hospitals" from U.S. News & World Report. UH is also home to Harrington Discovery Institute at University Hospitals – part of The Harrington Project for Discovery & Development. UH is the second largest employer in northern Ohio with 26,000 employees. For more information, go to UHhospitals.org. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/harrington-discovery-institute-at-university-hospitals-opens-call-for-harrington-rare-disease-scholar-award-300463164.html
Gunter N.L.,University Circle |
Zootaxa | Year: 2017
A complex of small scarabaeine dung beetles related to Lepanus Balthasar, 1966 (Coleoptera: Scarabaeidae: Scarabaein-ae) is described, based on morphological and molecular characters. There are two new genera, six new species, and seven new combinations, including the transfer of one species to a pre-existing genus, as follows. Matthewsius Gunter & Weir new genus includes two new species, M. stricklandensis Gunter & Weir new species from central New South Wales, Aus-tralia and M. vanleeuweni Gunter & Weir new species from Pilbara region of Western Australia, Australia; two species formerly included within Aptenocanthon Matthews, 1974, M. rossi (Matthews, 1974) new combination and M. speewah (Storey & Monteith, 2000) new combination; and two species formerly included within Lepanus, M. illawarrensis (Mat-thews, 1974) new combination and M. penelopae (Matthews & Weir, 2002) new combination. Monteithocanthon Gunter & Weir new genus includes six species: Monteithocanthon elliotensis Gunter & Weir new species, Monteithocanthon koombooloomba Gunter & Weir new species, and Monteithocanthon paraarator Gunter & Weir new species from north-ern Queensland, Australia; Monteithocanthon peckorum Gunter & Weir new species from southwestern Western Austra-lia; and two species formally included within Lepanus, Monteithocanthon arator (Matthews, 1974) new combination and Monteithocanthon glaber (Matthews, 1974) new combination. Sauvagesinella loftyensis (Matthews & Weir, 2002) new combination is transferred from Lepanus on the basis of genetic and morphological similarities. © 2017 Magnolia Press.
Cameron S.L.,Queensland University of Technology |
Lo N.,University of Sydney |
Bourguignon T.,Hokkaido University |
Svenson G.J.,University Circle |
Evans T.A.,National University of Singapore
Molecular Phylogenetics and Evolution | Year: 2012
Despite their ecological significance as decomposers and their evolutionary significance as the most speciose eusocial insect group outside the Hymenoptera, termite (Blattodea: Termitoidae or Isoptera) evolutionary relationships have yet to be well resolved. Previous morphological and molecular analyses strongly conflict at the family level and are marked by poor support for backbone nodes. A mitochondrial (mt) genome phylogeny of termites was produced to test relationships between the recognised termite families, improve nodal support and test the phylogenetic utility of rare genomic changes found in the termite mt genome. Complete mt genomes were sequenced for 7 of the 9 extant termite families with additional representatives of each of the two most speciose families Rhinotermitidae (3 of 7 subfamilies) and Termitidae (3 of 8 subfamilies). The mt genome of the well supported sister-group of termites, the subsocial cockroach Cryptocercus, was also sequenced. A highly supported tree of termite relationships was produced by all analytical methods and data treatment approaches, however the relationship of the termites + Cryptocercus clade to other cockroach lineages was highly affected by the strong nucleotide compositional bias found in termites relative to other dictyopterans. The phylogeny supports previously proposed suprafamilial termite lineages, the Euisoptera and Neoisoptera, a later derived Kalotermitidae as sister group of the Neoisoptera and a monophyletic clade of dampwood (Stolotermitidae, Archotermopsidae) and harvester termites (Hodotermitidae). In contrast to previous termite phylogenetic studies, nodal supports were very high for family-level relationships within termites. Two rare genomic changes in the mt genome control region were found to be molecular synapomorphies for major clades. An elongated stem-loop structure defined the clade Polyphagidae + (Cryptocercus+. termites), and a further series of compensatory base changes in this stem-loop is synapomorphic for the Neoisoptera. The complicated repeat structures first identified in Reticulitermes, composed of short (A-type) and long (B-type repeats) defines the clade Heterotermitinae + Termitidae, while the secondary loss of A-type repeats is synapomorphic for the non-macrotermitine Termitidae. © 2012 Elsevier Inc.
News Article | November 3, 2016
CLEVELAND, Nov. 3, 2016 /PRNewswire/ -- Today, The Music Settlement (TMS) at University Circle announced its new President & CEO: Geralyn 'Geri' Presti, who is returning to TMS after an extraordinary tenure at Forest City Realty Trust, Inc. (previously Forest City Enterprises), where...
Evans D.C.,Royal Ontario Museum |
Evans D.C.,University of Toronto |
Schott R.K.,University of Toronto |
Larson D.W.,University of Toronto |
And 3 more authors.
Nature Communications | Year: 2013
Taphonomic biases dictate how organisms are represented in the fossil record, but their effect on studies of vertebrate diversity dynamics is poorly studied. In contrast to the high diversity and abundance of small-bodied animals in extant ecosystems, small-bodied dinosaurs are less common than their large-bodied counterparts, but it is unclear whether this reflects unique properties of dinosaurian ecosystems or relates to taphonomic biases. A new, fully domed pachycephalosaurid dinosaur, Acrotholus audeti, from the Santonian of Alberta predates incompletely domed taxa, and provides important new information on pachycephalosaur evolution and the completeness of the ornithischian fossil record. Here we provide the first empirical evidence that the diversity of small-bodied ornithischian dinosaurs is strongly underestimated based on ghost lineages and the high proportion of robust and diagnostic frontoparietal domes compared with other pachycephalosaur fossils. This suggests preservational biases have a confounding role in attempts to decipher vertebrate palaeoecology and diversity dynamics through the Mesozoic. © 2013 Macmillan Publishers Limited. All rights reserved.
Mallon J.C.,University of Calgary |
Evans D.C.,Royal Ontario Museum |
Ryan M.J.,University Circle |
Anderson J.S.,University of Calgary
Palaeogeography, Palaeoclimatology, Palaeoecology | Year: 2012
Ongoing research into the biostratigraphy of the upper Campanian Dinosaur Park Formation (DPF) of Alberta has demonstrated that megaherbivorous dinosaur taxa (ankylosaurs, ceratopsids, hadrosaurids) are not homogeneously distributed throughout the unit. This has compelled proposals of different, informal assemblage zone schemes, and the hypothesis that faunal turnover was driven by environmental change associated with marine transgression. The current study tests previous zonation schemes in addition to the hypothesis of turnover pulses in the DPF. Clustering and ordination methods are used to demonstrate the existence of two broad assemblage zones within the DPF, each of which lasted ~. 600. Ka: a lower zone characterized by the presence of the ceratopsid Centrosaurus apertus and the hadrosaurids Corythosaurus, and an upper zone characterized by the presence of the ceratopsid Styracosaurus albertensis and the hadrosaurid Prosaurolophus maximus. These zones can be further sub-divided, based on the distributions of rarer or shorter-lived ankylosaur, ceratopsid, and hadrosaurid species, into ~. 300. Ka sub-zones. Canonical correspondence analysis is used to explore the association between the turnover of the megaherbivorous dinosaurs and various palaeoevironmental proxies. Megaherbivorous dinosaur turnover most closely corresponds to that of fossil palynomorphs. However, none of the palaeoenvironmental proxies explains dinosaur distribution better than a simple time gradient, suggesting that dinosaur turnover was not inextricably linked to environmental change as predicted by the turnover pulse hypothesis. © 2012 Elsevier B.V.
Mallon J.C.,University of Calgary |
Holmes R.,University of Alberta |
Eberth D.A.,Royal Tyrrell Museum of Palaeontology |
Ryan M.J.,University Circle |
Anderson J.S.,University of Calgary
Journal of Vertebrate Paleontology | Year: 2011
Anchiceratops is a chasmosaurine ceratopsid from the Upper Cretaceous Horseshoe Canyon Formation (HCF) of Alberta. It is distinguished primarily by its unique parietosquamosal frill ornamentation and possibly by the presence of a ventrally flexed olfactory bulb of the brain. Although Anchiceratops is known from at least ten partial skulls, only two of these have been formally described. These skulls are not stratigraphically segregated, but they differ markedly in their proportions (e.g., supraorbital horncore and frill dimensions), causing previous authors to account for this disparity with reference to either interspecific or sexual differences. Both of these hypotheses assume that variation in Anchiceratops is dimorphic; however, this assumption has never been tested with reference to all available material. The present study describes all material from the HCF that can be positively attributed to Anchiceratops, and tests the assumption of dimorphism by subjecting this material to a series of morphometric analyses. We find no compelling evidence for dimorphism in Anchiceratops, although sample size is still too small for convincing statistical support. We conclude that there is a single, variable species of Anchiceratops, A. ornatus. Average sedimentation rates for the HCF suggest that A. ornatus is a particularly long-lived species compared with other ceratopsids (1.5-2.0 Ma), and the paleoecological implications of this are discussed. A cladistic analysis that includes the new data presented here indicates that Anchiceratops is more closely related to Chasmosaurus than to Triceratops, in contrast with previous studies. © 2011 by the Society of Vertebrate Paleontology.
Mallon J.C.,Canadian Museum of Nature |
Ryan M.J.,University Circle |
Campbell J.A.,University of Calgary
Zoological Journal of the Linnean Society | Year: 2015
Disentangling ontogenetic from interspecific variation is key to understanding biodiversity in the fossil record, yet information on growth in the ceratopsid subfamily Chasmosaurinae is sparse. Here, we describe the partial skull of a juvenile chasmosaurine, attributed to Arrhinoceratops brachyops, within the context of more mature specimens of this species, to better understand the ontogenetic transformations therein. We show that as A. brachyops matured, the postorbital horncores became longer and shifted from a posterior to an anterior inclination, the delta-shaped frill epiossifications became lower and fused to the underlying frill, and the face became more elongate. In these respects, A. brachyops closely resembled Triceratops, suggesting that these ontogenetic changes may have been common to all long-horned chasmosaurines. However, an event-paired cladistic analysis of Chasmosaurinae using a standardized matrix of 24 developmental characters reveals that the relative timing of ontogenetic events in Arrhinoceratops was more like that of Chasmosaurus, particularly in the relatively late reduction in scalloping around the frill margins. Thus, the ontogenetic similarities between Arrhinoceratops and Triceratops appear to be plesiomorphic, partly related to the retention of the elongate postorbital horncores, which are primitive for Ceratopsidae. This study elucidates the otherwise contentious evolutionary relationships of Arrhinoceratops, and highlights the importance of ontogenetic data for resolving phylogenies when morphological data from adults alone are inadequate. © 2015 The Linnean Society of London.
News Article | September 3, 2016
The Cleveland Heights, Ohio–based car dealership Motorcars Honda was named the first carbon-neutral automotive dealership anywhere in the world at a recent awards ceremony in the city, according to a new press release. The new “Carbon Neutral Award” status was granted by British Petroleum (BP), ironically, at an event “for more than 5,000 residents and businesses at Wade Oval in University Circle.” What has Motorcars Honda done to date to deserve such a distinction? Apparently, it installed solar photovoltaic (PV) panels as well as “LG VRF systems heating/cooling system, and LED lighting fixtures,” amongst other things. “We are eliminating the carbon footprint for every new & used cars sold, all of our employees cars, parts truck, rental cars, shuttle van, and the owners personal travel tied to work,” stated Trevor Gile, Managing Partner at Motorcars Honda. “Five years ago, we never thought that we would be going down this path, but as our employees became more involved and concerned with the environment, we started to learn about some of the various options available to help.” Here’s some background on the dealership: “Motorcars Honda is an automotive dealership in Cleveland Heights, OH. Founded in 1971. Motorcars Honda has received many awards including Honda’s Environmental Leadership Platinum Award — 1 of only 10 dealers in the country to win this award, Winner of 2015 Ohio Business of the Year (Green Energy of Ohio), Winner of 2016’s “Dealer of the Year” for Ohio (DealerRater) and ranked top 100 dealerships to work for in America (Automotive News), just to name a few.” It’s hard to believe this is the first carbon-neutral car dealership in the world, but I guess that also makes a bit of sense. Drive an electric car? Complete one of our short surveys for our next electric car report. Keep up to date with all the hottest cleantech news by subscribing to our (free) cleantech newsletter, or keep an eye on sector-specific news by getting our (also free) solar energy newsletter, electric vehicle newsletter, or wind energy newsletter. James Ayre 's background is predominantly in geopolitics and history, but he has an obsessive interest in pretty much everything. After an early life spent in the Imperial Free City of Dortmund, James followed the river Ruhr to Cofbuokheim, where he attended the University of Astnide. And where he also briefly considered entering the coal mining business. He currently writes for a living, on a broad variety of subjects, ranging from science, to politics, to military history, to renewable energy. You can follow his work on Google+.